Lv51
1276 积分 2022-09-19 加入
In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury
49分钟前
已完结
Accelerating drug discovery through tight integration of expert molecular design and predictive scoring
2小时前
已完结
The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin αvβ6 Inhibitor for Fibrosis
2小时前
已完结
Molecular modeling and rational design of disulfide‐stapled self‐inhibitory peptides to target IL‐17A/IL‐17RA interaction
3天前
已完结
Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex
3个月前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
4个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
4个月前
已完结
Synthesis and Structure−Activity Relationships of Dimeric Peptide Antagonists of the Human Immunoglobulin G−Human Neonatal Fc Receptor (IgG−FcRn) Interaction
4个月前
已完结
Structure–activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction
4个月前
已关闭
Design of a Novel Globular Protein Fold with Atomic-Level Accuracy
4个月前
已完结
皖公网安备34019202002308
